{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T12:47:20Z","timestamp":1776689240711,"version":"3.51.2"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,19]]},"DOI":"10.7759\/cureus.54464","type":"journal-article","created":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T14:23:16Z","timestamp":1708352596000},"source":"Crossref","is-referenced-by-count":2,"title":["Giant Tophaceous Gout: The Importance of Therapeutic Compliance"],"prefix":"10.7759","author":[{"given":"Ricardo","family":"Silva Veiga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ines B","family":"Mesquita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joana","family":"Gomes da Cunha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Pedro Mota","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Gout: a review of its aetiology and treatment","volume":"10","author":"Li EK","year":"2004","unstructured":"Li EK. Gout: a review of its aetiology and treatment. Hong Kong Med J. 2004, 10:261-70.","journal-title":"Hong Kong Med J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.11604\/pamj.2015.22.132.6447","article-title":"Chronic tophaceous gout with unusual large tophi: case report","volume":"22","author":"Aradoini N","year":"2015","unstructured":"Aradoini N, Talbi S, Berrada K, Abourazzak FZ, Harzy T. Chronic tophaceous gout with unusual large tophi: case report. Pan Afr Med J. 2015, 22:132. 10.11604\/pamj.2015.22.132.6447","journal-title":"Pan Afr Med J"},{"key":"ref3","article-title":"Chronic tophaceous gout in an adult","volume":"23","author":"Ortiz OA","year":"2019","unstructured":"Ortiz OA, Cort\u00e9s RO, Torres MD. Chronic tophaceous gout in an adult. MediSan. 2019, 23:114-120.","journal-title":"MediSan"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S1138-3593(01)73933-0","article-title":"Tophaceous gout: about a case of giant tophi (Article in Portuguese)","volume":"27","author":"Centeno AM","year":"2001","unstructured":"Centeno AM, Domingo JG, Jimeno JB. Tophaceous gout: about a case of giant tophi (Article in Portuguese). Semergen. 2001, 27:149-51. 10.1016\/S1138-3593(01)73933-0","journal-title":"Semergen"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.13107\/jocr.2019.v10.i01.1640","article-title":"A case of surgically intervened chronic tophaceous gout and review of literature","volume":"10","author":"Sinha S","year":"2019","unstructured":"Sinha S, Rijal R, Shah J, Chaudhary P. A case of surgically intervened chronic tophaceous gout and review of literature. J Orthop Case Rep. 2019, 10:66-9. 10.13107\/jocr.2019.v10.i01.1640","journal-title":"J Orthop Case Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/medicina57010058","article-title":"Therapeutic strategies for the treatment of chronic hyperuricemia: an evidence-based update","volume":"57","author":"Cicero AF","year":"2021","unstructured":"Cicero AF, Fogacci F, Kuwabara M, Borghi C. Therapeutic strategies for the treatment of chronic hyperuricemia: an evidence-based update. Medicina (Kaunas). 2021, 57:58. 10.3390\/medicina57010058","journal-title":"Medicina (Kaunas)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/bcr.03.2009.1668","article-title":"Generalised chronic tophaceous gout","author":"Tristano AG","year":"2009","unstructured":"Tristano AG. Generalised chronic tophaceous gout. BMJ Case Rep. 2009, 10.1136\/bcr.03.2009.1668","journal-title":"BMJ Case Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.36707","article-title":"Atypical presentation of gout: a case report","volume":"15","author":"Abdel-Khalek A","year":"2023","unstructured":"Abdel-Khalek A, Tariq A, White JA, Cheema AR, Dhillon S, Tiesenga F. Atypical presentation of gout: a case report. Cureus. 2023, 15:36707. 10.7759\/cureus.36707","journal-title":"Cureus"},{"key":"ref9","article-title":"Diagnosis and management of acute gout","volume":"92","author":"Conway N","year":"2009","unstructured":"Conway N, Schwartz S. Diagnosis and management of acute gout. Med Health R I. 2009, 92:356-8.","journal-title":"Med Health R I"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.158.7.741","article-title":"Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: the systolic hypertension in the Elderly Program. SHEP Cooperative Research Group","volume":"158","author":"Savage PJ","year":"1998","unstructured":"Savage PJ, Pressel SL, Curb JD, et al.. Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: the systolic hypertension in the Elderly Program. SHEP Cooperative Research Group. Arch Intern Med. 1998, 158:741-51. 10.1001\/archinte.158.7.741","journal-title":"Arch Intern Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.5457","article-title":"Hyperuricemia associated with thiazide diuretics in hypertensive adults","volume":"11","author":"Raja R","year":"2019","unstructured":"Raja R, Kavita F, Amreek F, Shah A, Sayeed KA, Sehar A. Hyperuricemia associated with thiazide diuretics in hypertensive adults. Cureus. 2019, 11:5457. 10.7759\/cureus.5457","journal-title":"Cureus"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1080\/15257770.2011.616564","article-title":"Apical voltage-driven urate efflux transporter NPT4 in renal proximal tubule","volume":"30","author":"Jutabha P","year":"2011","unstructured":"Jutabha P, Anzai N, Wempe MF, Wakui S, Endou H, Sakurai H. Apical voltage-driven urate efflux transporter NPT4 in renal proximal tubule. Nucleosides Nucleotides Nucleic Acids. 2011, 30:1302-11. 10.1080\/15257770.2011.616564","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kex156","article-title":"The British Society for Rheumatology Guideline for the management of gout","volume":"56","author":"Hui M","year":"2017","unstructured":"Hui M, Carr A, Cameron S, et al.. The British Society for Rheumatology Guideline for the management of gout. Rheumatology (Oxford). 2017, 56:1-20. 10.1093\/rheumatology\/kex156","journal-title":"Rheumatology (Oxford)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/228942-giant-tophaceous-gout-the-importance-of-therapeutic-compliance","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T14:23:22Z","timestamp":1708352602000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/228942-giant-tophaceous-gout-the-importance-of-therapeutic-compliance"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,19]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.54464","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,19]]}}}